Biomarker-guided clustering of Alzheimer's disease clinical syndromes
Lists
Only you see this
Abstract
Alzheimer's disease (AD) neuropathology is extremely heterogeneous, and the evolution from preclinical to mild cognitive impairment until dementia is driven by interacting genetic/biological mechanisms not fully captured by current clinical/research criteria. We characterized the heterogeneous "construct" of AD through a cerebrospinal fluid biomarker-guided stratification approach. We analyzed 5 validated pathophysiological cerebrospinal fluid biomarkers (Aβ<sub>1-42</sub>, t-tau, p-tau<sub>181</sub>, NFL, YKL-40) in 113 participants (healthy controls [N = 20], subjective memory complainers [N = 36], mild cognitive impairment [N = 20], and AD dementia [N = 37], age: 66.7 ± 10.4, 70.4 ± 7.7, 71.7 ± 8.4, 76.2 ± 3.5 years [mean ± SD], respectively) using Density-Based Spatial Clustering of Applications with Noise, which does not require a priori determination of the number of clusters. We found 5 distinct clusters (sizes: N = 38, 16, 24, 14, and 21) whose composition was independent of phenotypical groups. Two clusters showed biomarker profiles linked to neurodegenerative processes not associated with classical AD-related pathophysiology. One cluster was characterized by the neuroinflammation biomarker YKL-40. Combining nonlinear data aggregation with informative biomarkers can generate novel patient strata which are representative of cellular/molecular pathophysiology and may aid in predicting disease evolution and mechanistic drug response.
BibTeX
@inproceedings{toschi2019biomarker,
author = {Nicola Toschi and Simone Lista and Filippo Baldacci and Enrica Cavedo and Henrik Zetterberg and Kaj Blennow and Ingo Kilimann and Stefan Teipel and Antonio Melo dos Santos and Stéphane Epelbaum and Foudil Lamari and Rémy Genthon and Marie‐Odile Habert and Bruno Dubois and Roberto Floris and Francesco Garaci and Andrea Vergallo and Harald Hampel and Hovagim Bakardjian and Habib Benali and Hugo Bertín and Joel Bonheur and Laurie Boukadida and Nadia Boukerrou and Enrica Cavedo and Patrizia A. Chiesa and Olivier Colliot and Bruno Dubois and Marion Dubois and Stéphane Epelbaum and Geoffroy Gagliardi and Rémy Genthon and Marie‐Odile Habert and Harald Hampel and Marion Houot and Aurélie Kas and Foudil Lamari and Marcel Lévy and Simone Lista and Christiane Metzinger and Fanny Mochel and Francis Nyasse and Catherine Poisson and Marie‐Claude Potier and Marie Revillon and Antônio dos Santos and Katia Santos Andrade and Marine Sole and Mohmed Surtee and Michel Thiebaut de Schotten and Andrea Vergallo and Nadjia Younsi},
title = {{Biomarker-guided clustering of Alzheimer's disease clinical syndromes}},
booktitle = {Neurobiology},
year = {2019},
doi = {10.1016/j.neurobiolaging.2019.08.032},
}Loading related content...